Stem Cell Assay Market Dynamics: Competitive Landscape Analysis With Forecast by 2030
Market Insights:
Stem Cells have been acknowledged for their promising
potential toward the development of various cutting-edge treatments for a
number of diseases. As such, stem cell assays have a rapidly growing market.
Stem cell assays are essentially the techniques used for analyzing living cells
by various parameters which ultimately help determine the biochemical and
cellular functioning of cells. This has immense promise in drug development
activities. Market Research Future's study of the market in its latest report
has found that the global Stem
Cell Assay Market Dynamics is on track to register a highly optimistic
outlook at a CAGR of 19.80% during the review period from 2017 to 2023.
Stem cell assays are a promising part of the biotechnology
field, which is growing at a rapid pace. The prevalence of chronic and several
lifestyle diseases has compelled the growth of drug development activities in
an effort to develop effective treatments. Diseases such as cancer and diabetes
are soaring at high rates and the demand for better, efficient and more
affordable treatments are driving the market toward growth. Healthcare
expenditure across the globe is increasing, and advancement in biotechnology
and other medical technologies is highly encouraging of market growth.
Government support toward drug development for chronic diseases has increased
stem cell assay research.
The market is held back by stringent government policies
associated with approval of drugs as well as the high procedural cost of stem
cell assays. Moreover, there is a lack of awareness regarding stem cell assays,
and as a result, there is a dearth of skilled professionals which restrains
market growth. However, growing healthcare activities and the increasing demand
for treatment is likely to bring stem cell assays to the forefront and
opportunities in the market are plentiful.
Key Players:
Prominent players included in MRFR’s report are Cell
Biolabs, Inc., Thermo Fisher Scientific, Hemogenix, Merck KGaA, Promega
Corporation, GE Healthcare, Bio-Rad Laboratories, Inc., Bio-Techne Corporation,
Cellular Dynamics International Inc., STEMCELL Technologies Inc., and others
Get Sample Report: https://www.marketresearchfuture.com/reports/stem-cell-assay-market-5656
Market Segmentation:
Market structure is determined by its various significant
sections which, in the report have been segmented on the basis of product,
technology, assay, application, end-user, and region. Products in the market
include flow cytometer, cell imaging systems, automated cell counter, kits, and
others. The kits segment has been sub-segmented and includes umbilical cord
stem cells, induced pluripotent stem cell kits, mesenchymal stem cell kits, and
others.
The technology used in stem cell assays include
microfluidics-based cell trap technologies, microfabricated assisted
technology, and others
Assays in the market include cell identification assays,
cell viability & toxicity assays, cell proliferation assays, cell apoptosis
assays, and others.
Applications of stem cell assays can be found in orthopedic
& musculoskeletal spine, dermatology, cardiovascular, central nervous
system, and others.
End-users of stem cell assays include research
organizations, academic institutes, biotechnology industries, academic
institutes, and others.
Regional Analysis:
The Americas have captured the dominant share of the global
market. The presence of North America in the region has had a significant
impact on the regions market share possession. The rapid adoption of advanced
medical technologies and the presence of a large patient population for various
chronic diseases drive the Americas' market. Moreover, the regions healthcare
expenditure is rising, and there are several leading players present in the
North American sub-market.
Meanwhile, growing at the fastest pace is the Asia Pacific
regional market. Gradually increasing awareness regarding advanced medical
biotechnology is strongly impacting growth in the region. Several emerging
economies in the region have a rapidly growing biotechnology sector which
fuelling market growth. Findings by the Indian Brand Equity Foundation suggest
that the Indian subcontinent has 2% of the global biotechnology share. Several
opportunities in the region are expected to lead to market proliferation.
Access Report Details @ https://www.marketresearchfuture.com/reports/stem-cell-assay-market-5656
Browse Related Report:
Pharmaceutical
Grade Lactose Market Research Report- forecast till 2027
Intracranial
Pressure (ICP) Monitoring Market Research Report - Global Forecast to 2027
Home
Medical Equipment Market Research Report - Global Forecast till 2027
At Market Research Future (MRFR), we enable our customers
to unravel the complexity of various industries through our Cooked Research
Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients. Our market research studies by
Components, Application, Logistics and market players for global, regional, and
country level market segments, enable our clients to see more, know more, and
do more, which help to answer all their most important questions.
Contact:
Market Research Future®
99 Hudson Street,5Th Floor
New York, New York 10013
United States of America
Phone:
+1 628 258 0071(US)
+44 2035 002 764(UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
Comments
Post a Comment